Adult
130
27
29
59
Key Insights
Highlights
Success Rate
84% trial completion
Research Maturity
59 completed trials (45% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
8.5%
11 terminated out of 130 trials
84.3%
-2.3% vs benchmark
4%
5 trials in Phase 3/4
5%
3 of 59 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 59 completed trials
Clinical Trials (130)
Cognitive Neuroscience of Autism Spectrum Disorders
Effects of Rapid-Resisted Exercise and Bright Light Therapy on Ambulatory Adults With Traumatic Brain Injury
The Effects of Endotracheal Suctioning on Pain and Serum Markers
A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
Hydroponic vs Conventional Spinach Smoothies: Effects on Salivary Nitrate Bioavailability and Blood Pressure
Study of New Magnetic Resonance Imaging Methods of the Brain
Evaluation of an Instructional Video About Medication Management During Admission and Medication Adherence for Kidney Transplantation and in the Outpatient Clinic in a Dutch University Hospital.
Biomarkers in Bone Marrow Supernatant for Predicting AML Chemosensitivity
The Impact of Hunova® Robotic Platform Rehabilitation
GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients With Advanced Lung Cancer
GT201 Injection in Combination With Teraplizumab Injection for Treatment of Patients With Non-small Cell Lung Cancer
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (Advanced Cervical Cancer)
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients With Recurrent or Metastatic Cervical Cancer
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours
IB-T101 Injection for Treatment of Patients With Advanced Clear Cell Renal Cell Carcinoma
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Advanced Colorectal Cancer
LasaiON is an Evidence-informed, Multimodal Self-regulation Program Designed to Reduce Emotional Distress and Strengthen Stress-regulation Skills by Combining Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) With Breathing Supported by Heart-rate Variability Biofeedback (HRV-B; emWave).
Peanuts for Cardiometabolic, Brain, and Intestinal Health